batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Bladder no-go, but Trodelvy has bigger problems 18 October 2024 LaNova enters oncology’s hottest licensing territory 18 October 2024 New Roche/Poseida project isn’t P-BCMACD19-ALLO1 18 October 2024 Roche says no to MAGE-A4... again 16 October 2024 Merck keeps its kinase inhibitor options open 15 October 2024 No easy ride for Turnstone 14 October 2024 Itovebi’s window of opportunity 14 October 2024 Transgene stumbles with its fixed immunotherapy 14 October 2024 Load More